DCM
KIN

Driehaus Capital Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Driehaus Capital Management’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19,806
Closed -$170K – 652
2017
Q2 		$170K Buy
+19,806
New +$142K 0.01% 520
2014
Q4 		– Sell
-131,615
Closed -$1.22M – 625
2014
Q3 		$1.22M Sell
131,615
-49,131
-27% -$664K 0.05% 404
2014
Q2 		$3.37M Buy
180,746
+37,876
+27% +$643K 0.11% 254
2014
Q1 		$2.65M Buy
142,870
+1,351
+1% +$25.8K 0.08% 287
2013
Q4 		$1.58M Buy
+141,519
New +$1.69M 0.06% 348

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Driehaus Capital Management's KIN Position: Q3 2017 in Review

Driehaus Capital Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2017, closing a stake of 19,806 shares — an estimated $170K sold.

Driehaus Capital Management first reported a position in KIN in Q4 2013 and held it in 5 quarters. The position peaked at $3.37M in Q2 2014. 67 funds tracked by Wall St. Rank hold KIN as of Q3 2017.

  • Driehaus Capital Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2017 after selling out during the quarter.
  • Driehaus Capital Management sold 19,806 Kindred Biosciences, Inc. shares in Q3 2017, an estimated $170K.
  • Driehaus Capital Management first reported a position in Kindred Biosciences, Inc. in Q4 2013 and held it in 5 quarters.
  • Driehaus Capital Management's Kindred Biosciences, Inc. position peaked at $3.37M in Q2 2014.
  • 67 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2017.

Based on Driehaus Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.